New hip fractures add £1.1 billion to the cost of running hospitals each year in the UK, a study has found.Read the full story ›
Guinea's President Alpha Conde has announced new emergency measures enabling authorities to restrict movements in the west of the country where Ebola transmission continues a year after the epidemic was declared.
More than 10,300 people have died from Ebola in West Africa and while cases are thought to have peaked, Guinea is struggling to stamp out the virus.
Following a dip in new cases in January, they have spiked again since early March in and around the capital, prompting officials to announce a new phase of the epidemic in Guinea.
Speaking on state television Conde said: "I declare in the districts of Forecariah, Coyah, Dubreka, Boffa and Kindia a reinforcement of emergency measures for a period of 45 days.
"Wherever the need may be, throughout this period, measures of restriction and confinement will be taken".
Food and medical supplies would be given to the affected communities, Conde added.
Charities have welcomed the news that the government has reached an agreement with drug maker GlaxoSmithKline (GSK) to provide all babies in the UK with a potentially life-saving vaccine against meningitis B.
Sue Davie, chief executive of Meningitis Now, said: "To know that babies will be protected against MenB is fantastic and another great step forward in our fight against meningitis.
"Families for whom this comes too late, and for whom we will always be here to support, have campaigned tirelessly and selflessly with us to make sure no other families suffer as they have."
Chris Head, chief executive of Meningitis Research Foundation, said: "When this vaccine is introduced it will save lives and spare countless families the trauma of seeing a loved one die or become seriously disabled because of MenB."
GSK said the deal represented "fair value" for the health service.
Nikki Yates, general manager of GSK in the UK said: "As a British company, we are delighted to have concluded an agreement with the Government just three weeks after we acquired the vaccine, which offers fair value to the NHS and at the same time is sustainable for GSK."
The government has reached a deal with drug maker GlaxoSmithKline (GSK) to provide all babies in the UK with a potentially life-saving vaccine against meningitis B, Health Secretary Jeremy Hunt has announced.
Mr Hunt said Britain would now become the first country in the world with a nationwide meningitis B vaccination programme.
The deal follows recent controversy over the Bexsero MenB vaccine after it emerged it was still not available to children despite being recommended by health advisers a year ago.
The drug will now be added to the national childhood immunisation scheme, meaning babies will receive the first vaccine at two months old, followed by two further doses.
Mr Hunt said: "I am very proud that we will be the first country in the world to have a nationwide MenB vaccination programme, helping to protect our children from a devastating disease.
"MenB can be severely disabling or fatal, especially in babies and young children. Losing a child is every parent's worst nightmare so I am delighted that we have reached an agreement with GSK to supply the vaccine."
Police have reportedly fired tear gas at an angry crowd in Sierra Leone after stones were thrown at officials during a three-day national lockdown.
According to Reuters the unrest came as officials ordered some six million residents to stay inside on pain of arrest as health officials go door-to-door looking for hidden patients in the hopes of accelerating the end of the Ebola epidemic.
Women, including victims of human trafficking are missing out on care because of confusion over 'health tourists', a charity has warned.Read the full story ›
Half of teachers said the number of youngsters dealing with difficulties, such as depression, has risen compared to two years ago.Read the full story ›
A woman who was Liberia's last known patient with Ebola has died, according to a senior health official in the country.
Corporal Anna Cross has thanked doctors after being declared free of Ebola following the help of experimental treatment.
The British military medic became the first person in the world to be treated with the drug MIL 77.
She contracted the potentially deadly virus in Sierra Leone having complained of being "tired" but not ill, as ITV News' Paul Davies reports:
Ebola-free corporal Anna Cross has described how she dealt with the shock of being diagnosed with the potentially deadly virus in Sierra Leone, having not felt particularly ill but just "tired".
She said it "was hard for a few hours and then something in my mind just kicked in as it does in difficult situations and it said 'I have a job to do', which is to get myself back well, and I started to really focus on the people around me".
The 25-year-old was full of praise for the medics at the Royal Free Hospital in London as well as her fellow volunteers in Africa who helped her through the initial stages.
I was looked after by the colleagues that I had worked with and that gave me such confidence because they're total professionals and they were really dedicated to getting me home, to getting my health optimised, to get me on the flight, which they did within less than 24 hours of me being diagnosed, and a fantastic RAF team brought me home.